[{"type": "title", "data": "OB Antepartum VTE Prophylaxis (Enoxaparin)"}, {"type": "category", "data": "Patient Care"}, {"type": "note", "data": "This order set is intended for antepartum patients being admitted to any floor in the hospital (Medicine, Surgery, Obstetrics etc.) requiring PROPHYLACTIC DOSE thromboprophlyaxis.&nbsp; "}, {"type": "note", "data": "Do NOT use for pateints requiring INTERMEDIATE or THERAPEUTIC DOSE thromboprophylaxis"}, {"type": "note", "data": "If patient is receiving&nbsp; Low Molecular Weight Heparin (enoxaparin) antenatally prior to admission, continue the antenatal LMWH regimen"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "VTE Risk is Moderate or High Without Contraindication to Anticoagulants"}, {"type": "order", "data": "enoxaparin", "value": ""}, {"type": "sentence", "data": "20 mg, SubQ, Injection, q24hr(sched)"}, {"type": "sentence", "data": "40 mg, SubQ, PFS, q24hr(sched)"}, {"type": "sentence", "data": "60 mg, SubQ, Injection, q24hr(sched)"}, {"type": "sentence", "data": "80 mg, SubQ, Injection, q24hr(sched)"}, {"type": "sentence", "data": "0.3 mg/kg, SubQ, Injection, q12hr(sched)"}, {"type": "note", "data": "VTE Risk is Moderate or High With Contraindication to Anticoagulants "}, {"type": "note", "data": "If prophylactic medication is CONTRAINDICATED in patient with active bleeding or high risk of bleeding, or contraindication to heparin or LMWH, then use mechanical VTE prophylaxis"}, {"type": "order", "data": "Graduated Compression Stocking", "value": ""}, {"type": "sentence", "data": "T;N, Full length; 30- 40 mmHg"}, {"type": "order", "data": "Graduated Compression Stocking", "value": ""}, {"type": "sentence", "data": "T;N, Calf length; 30- 40 mmHg"}, {"type": "note", "data": "VTE Risk is low"}, {"type": "order", "data": "Communication Order", "value": ""}, {"type": "sentence", "data": "T;N, VTE Prophylaxis Not Indicated"}, {"type": "note", "data": "Low Molecular Weight Heparin (LMWH) is contraindicated for patients with history of Heparin Induced Thrombocytopenia (HIT)"}, {"type": "note", "data": "ASRA guideline: At least 36 hours before induction of labour or cesarean delivery, LMWH should be discontinued and the patient converted to IV or SC unfractioned heparin (UFH) if needed. Intravenous UFH should be discontinued 4 to 6 hours before anticipated delivery. "}, {"type": "note", "data": "Prophylactic dose thromboprophylaxis is recommended for the following antepartum patients (i.e. absolute risk greater than 1%): - non-obstetrical surgery during pregnancy, with the duration of thromboprophylaxis procedure - and patient- dependent - strict antepartum bed rest for greater than or equal to 7 days in a woman with body mass index of greater than 25 kg/m2 at her first antenatal visit. - personal history of previous unprovoked venous thromboembolism - personal history of a previous venous thromboembolism related to oral contraceptives or pregnancy - personal history of a previous provoked venous thromboembolism and any low risk thrombophilia - asymptomatic homozygous factor V Leiden - asymptomatic homozygous prothrombin gene mutation 20210A - asymptomatic combined thrombophilia - asymptomatic antithrombin deficiency "}, {"type": "category", "data": "Consults/Referrals"}, {"type": "note", "data": "For patients who may require newly started intermediate or therapeutic dose anticoagulation, consider a consult to Internal Medicine. "}, {"type": "order", "data": "Consult to Internal Medicine", "value": ""}]
